Alpha Tau Medical (DRTS) Accounts Payables (2020 - 2026)

Alpha Tau Medical (DRTS) has 7 years of Accounts Payables data on file, last reported at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 44.28% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 44.28% YoY), and the FY2025 full-year result was $3.9 million, up 9.54% from the prior year.
• Accounts Payables declined to $3.7 million in Q1 2026, from $3.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.9 million in Q4 2025 to a low of $1.2 million in Q2 2022.
• A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Accounts Payables.
• Peak annual rise in Accounts Payables reached 80.32% in 2023, while the deepest fall reached 45.99% in 2023.
• Tracing DRTS's Accounts Payables over 5 years: stood at $1.4 million in 2022, then jumped by 80.32% to $2.6 million in 2023, then jumped by 37.61% to $3.5 million in 2024, then rose by 9.54% to $3.9 million in 2025, then retreated by 3.88% to $3.7 million in 2026.
• Business Quant data shows DRTS's Accounts Payables at $3.7 million in Q1 2026, $3.9 million in Q4 2025, and $3.1 million in Q3 2025.